FinancialContent is the trusted provider of stock market information to the media industry.
March 14, 2012 at 17:42 PM EDT
Endocyte Applies For European Marketing Authorization

Endocyte Inc. (Nasdaq: ECYT) will apply for conditional marketing authorization with the European Union for its ovarian cancer treatments EC145 and EC20. Shares of the biopharmaceutical leaped $2.17 to close at $5.89.


Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More